Synonyms: AZD 9056 | AZD-9056
Compound class:
Synthetic organic
Comment: AZD9056 is a potent, selective, orally bioavailable P2X7 receptor antagonist.
This compound was in the AstraZeneca/NCATS repurposing list from 2012. |
|
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Rheumatoid arthritis |
Disease Ontology:
DOID:7148 OMIM: 180300 |
Reached Phase 2 clinical evaluation in RA, but development was discontinued. | |
Crohn's disease |
Disease Ontology:
DOID:8778 OMIM: 266600 Orphanet: ORPHA206 |
Developed with potential for treating CD, but development was discontinued. | |
Chronic obstructive pulmonary disease |
Disease Ontology:
DOID:3083 |
Developed with potential for treating COPD, but development was discontinued. |